Joshua Welch, PhD, is awarded a new Chan Zuckerberg Initiative grant

Joshua Welch, Ph.D., an associate professor in the Department of Computational Medicine and Bioinformatics (DCMB) was awarded a Chan Zuckerberg Initiative (CZI) grant for his project titled: “Atlas-scale Hierarchical Identification of Cell Types and Functions.”

With this new funding, the Welch lab will develop an AI approach for identifying the type of a cell from its gene expression. While many previous approaches for this problem exist, theirs is unique in its ability to use both general and specific cell type annotations to calibrate its predictions. Another unique aspect of this project is in predicting the functions that cells can perform based on gene expression. The ability to predict these properties would save much time and standardize the vocabulary scientists use when analyzing single cell RNA sequencing (scRNA) data.

“We are excited to work toward better cell type classification algorithms, and we're grateful for both the funding and the infrastructure that CZI has developed that makes this project possible.”—Joshua Welch, Ph.D.

This project depends on the availability of many high-quality scRNA datasets with manually curated labels. The Welch team plans to use CZI's CZ CELLxGENE Discover Census dataset, which is the largest single collection of scRNA data in which every cell is labeled with a cell ontology term. 

This project will use the latest neural network approaches to develop an AI approach that can label cells. The key challenge for this project is to address the laborious, subjective, and error-prone nature of manually labeling cell types. The latest AI models provide a promising solution to this challenge.

Welch and his Ph.D. candidate Jialin Liu already received a grant from CZI in 2023 for developing two novel computational tools that detect signaling among single cells from spatial transcriptomic data. Read more.

Congratulations, Dr. Welch!

In This Story
Joshua Welch Joshua Welch, PhD

Associate Professor

Featured News & Stories headshot of Carrie Ferrario
Department News
ORTDD career development spotlight featuring Dr. Carrie Ferrario
ORTDD career development spotlight featuring Dr. Carrie Ferrario
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
IUD 101
IUDs are becoming one of the most popular forms of birth control for all ages. In this episode, we cover a recent Health Lab article Q&A on IUDs with Dr. Monica Rosen of University of Michigan Health.
man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
surgical area of clinicians drawn out with blue background
Health Lab
New tools that leverage NIH’s ‘All of Us’ dataset could improve anesthesia and surgical care
In a report in JAMA Surgery, researchers propose two novel tools that leverage the All of Us dataset to look at acute health events such as surgery.
Dr. Adina Turcu
Department News
Internal Medicine Faculty Spotlight − Dr. Adina Turcu
Adina Turcu, MD, MS is an Associate Professor of Internal Medicine in the Division of Metabolism, Endocrinology & Diabetes, dedicated to providing comprehensive and compassionate care to her patients.
prescription pad drawn
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.